Janus Henderson Group PLC Wave Life Sciences Ltd. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Janus Henderson Group PLC holds 51,700 shares of WVE stock, worth $693,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,700

Previous 51,700 -0.0%

Holding current value

$693,297

Previous $257,000 64.59%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$4.38 - $6.48 $226,446 - $335,016	51,700 New	51,700 $257,000
Q1 2020 May 14, 2020	SELL	$6.94 - $14.22 $5.57 Million - $11.4 Million	-802,742 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$7.99 - $37.6 $26.2 Million - $123 Million	-3,274,718 Reduced 80.31%	802,742 $6.43 Million
Q3 2019 Nov 14, 2019	BUY	$19.17 - $27.4 $13.1 Million - $18.8 Million	685,162 Added 20.2%	4,077,460 $83.7 Million
Q2 2019 Jul 31, 2019	BUY	$22.93 - $42.84 $10.8 Million - $20.2 Million	470,402 Added 16.1%	3,392,298 $88.5 Million
Q1 2019 Apr 30, 2019	BUY	$32.69 - $47.91 $41.9 Million - $61.4 Million	1,280,702 Added 78.03%	2,921,896 $114 Million
Q4 2018 Feb 06, 2019	BUY	$37.1 - $50.11 $4.62 Million - $6.23 Million	124,414 Added 8.2%	1,641,194 $69 Million
Q3 2018 Nov 09, 2018	SELL	$36.35 - $55.2 $71,900 - $109,185	-1,978 Reduced 0.13%	1,516,780 $75.8 Million
Q2 2018 Aug 10, 2018	BUY	$33.85 - $50.65 $5.43 Million - $8.13 Million	160,545 Added 11.82%	1,518,758 $58.1 Million
Q1 2018 May 14, 2018	BUY	$32.45 - $54.7 $21.1 Million - $35.5 Million	648,989 Added 91.51%	1,358,213 $54.5 Million
Q4 2017 Feb 09, 2018	BUY	$21.8 - $39.35 $15.5 Million - $27.9 Million	709,224	709,224 $24.9 Million

Others Institutions Holding WVE

# of Institutions

164

Shares Held

117M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.16B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Wave Life Sciences Ltd. Transaction History